Journal List > J Korean Med Assoc > v.52(7) > 1042186

Kim: Pharmacotherapy of Insomnia

Abstract

As insomnia is a common symptom caused by diverse disorders, treatment tools for the insomnia differ depending on the underlying cause. Hypnotics can be used for primary insomnia. As hypnotics show excellent short-term efficacy, they would be useful as short-term (< 4 weeks) treatments for transient insomnia. There has been much controversy over long-term hypnotic use for chronic insomnia. Evidence supporting safety and efficacy of the long-term hypnotic use is insufficient. Therefore, rather than using hypnotics alone, non-pharmacological treatments are recommended more for chronic primary insomnia. Although various benzodiazepines have widely been used as hypnotics, there have been concerns over tolerance, rebound insomnia, dependency, cognitive decline and psychomotor slowness. In efforts to relieve these concerns, selective benzodiazepine agonists like zolpidem have been introduced as novel hypnotics. Sedating antidepressants, melatonin and anti-histamine have also been used in order to manage insomnia. However, their efficacy for primary insomnia has yet to be proven.

Figures and Tables

Table 1
Characteristics of benzodiazepine receptor agonist used for insomnia.
jkma-52-719-i001

References

1. Kryger MH, Roth T, Dement WC, editors. Principle and practice of sleep medicine. 2005. Philadelphia: Elsevier;444–467. 726–760.
2. Bain KT. Management of chronic insomnia in elderly persons. Am J Geriatr Pharmacother. 2006. 4:168–192.
crossref
3. Wilson S, Nutt D. Drug treatment of chronic insomnia - dawn at the end of a long night? J Psychopharmacol. 2008. 22:703–706.
crossref
4. Riemann D, Perlis ML. The treatments of chronic insomnia: A review of benzodiazepine receptor agonists and psychological and behavioral therapies. Sleep Med Rev. 2009. 13:205–214.
crossref
5. Dubovsky S. Sadock BJ, Sadock VA, editors. Benzodiazepine receptor agonists and antagonists. Comprehensive textbook of psychiatry. 2005. Philadelphia: Lippincott Williams & Wilkins;2781–2791.
TOOLS
Similar articles